IL-2 Fibroblasts

Developed for: leukemia
Investigated by: Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · The Methodist Hospital Research Institute

today NCT00058799 · Ph 1

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT00058799	Jun 1999 → Jun 2010	leukemia	Baylor College of Medicine	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	IL-2 Fibroblasts	“Leukemic Blasts 2 x 10\^7; IL-2 Fibroblasts 2 x 10\^7; CD40L Fibroblasts 2 x 10\^5” NCT00058799 ↗
Modality	Cell therapy	“gene-modified CD40L and IL-2 skin fibroblasts” NCT00058799 ↗
Route	Subcutaneous	“The modified fibroblasts will be injected with a number of leukemic cells under the skin.” NCT00058799 ↗